These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35925120)
41. Don't judge a book by its cover: a case report of apolipoprotein A-IV cardiac amyloidosis. Basel Allaw M; Sinha A; Ghafourian K; Avery R; Weinberg RL; Lomasney JW; Shah SJ; Patel RB Eur Heart J Case Rep; 2023 Aug; 7(8):ytad341. PubMed ID: 37681056 [TBL] [Abstract][Full Text] [Related]
42. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902 [TBL] [Abstract][Full Text] [Related]
43. Amyloid Cardiomyopathy in the Emergency Department. Baca M; Newberry M J Emerg Med; 2019 Feb; 56(2):205-209. PubMed ID: 30553561 [TBL] [Abstract][Full Text] [Related]
44. Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy. Nelson LM; Penninga L; Villadsen GE; Mølgaard H; Eiskjaer H; Hillingsø JG; Rasmussen A Clin Transplant; 2015 Dec; 29(12):1098-104. PubMed ID: 26361241 [TBL] [Abstract][Full Text] [Related]
45. The paramount importance of repeated left ventricular endomyocardial biopsy during the diagnosis of restrictive cardiomyopathy due to AL cardiac amyloidosis. Rubiś P; Rudnicka-Sosin L; Jurczyszyn A; Janion M; Podolec P Kardiol Pol; 2016; 74(8):796. PubMed ID: 27553348 [No Abstract] [Full Text] [Related]
46. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976 [TBL] [Abstract][Full Text] [Related]
47. Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia. Nojima Y; Ihara M; Kurimoto T; Nanto S Am J Case Rep; 2016 Apr; 17():235-40. PubMed ID: 27064109 [TBL] [Abstract][Full Text] [Related]
48. Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction. Ton VK; Mukherjee M; Judge DP Clin Med Insights Cardiol; 2014; 8(Suppl 1):39-44. PubMed ID: 25628512 [TBL] [Abstract][Full Text] [Related]
58. [Restrictive cardiomyopathy as a manifestation of primary amyloidosis]. Brychta T; Parenica J; Zatocil T; Manousek J; Tesák M; Schildberger J; Kala P; Semrád B; Brázdil J; Cíhalová M Vnitr Lek; 2004 Jan; 50(1):66-71. PubMed ID: 15015232 [TBL] [Abstract][Full Text] [Related]
59. A case of cardiac amyloidosis incidentally detected by bone scintigraphy. Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354 [TBL] [Abstract][Full Text] [Related]
60. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management. Hassan W; Al-Sergani H; Mourad W; Tabbaa R Tex Heart Inst J; 2005; 32(2):178-84. PubMed ID: 16107109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]